Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis

Laboratory Investigation

Volumn 82, Issue 5, 2002, Pages 563-569

  Lin, Feng ^a   Emancipator, Steven N ^a   Salant, David J ^b   Medof, M Edward ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CD59 ANTIGEN; COMPLEMENT; CREATININE; DECAY ACCELERATING FACTOR; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL PROTECTION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ELECTRON MICROSCOPY; FLOW CYTOMETRY; IMMUNE COMPLEX NEPHRITIS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ALBUMINURIA; ANIMALS; ANTIGENS, CD55; COMPLEMENT C3; COMPLEMENT PATHWAY, CLASSICAL; DISEASE MODELS, ANIMAL; FEMALE; GLOMERULONEPHRITIS; IMMUNOGLOBULIN G; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEINURIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0036097127     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780451     Document Type: Article

References (31)

1. Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney
2. Decay-accelerating factor is present on rat glomerular epithelial cells in vivo
3. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: Evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury
4. Aminopeptidase A: A nephritogenic target antigen of nephrotoxic serum
5. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells
6. Role of terminal complement pathway in the heterologous phase of antiglomerular basement membrane nephritis
7. Acute nephrotoxic serum nephritis in complement knockout mice: Relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria
8. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria
9. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein
10. A direct comparison of complement inhibitory capacities of the GPI- and transmembrane forms of mouse DAF to mouse Crry and human rsCR1
11. Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and sitespecific monoclonal antibodies
12. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis
13. In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats
14. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes
15. Complement regulatory proteins in glomerular diseases
16. The role of a complement regulatory protein in rat mesangial glomerulonephritis
17. Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement
18. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement
19. Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury
20. Characterization of rat complement receptors and regulatory proteins: CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1
21. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor
22. Decay accelerating factor regulates complement activation on glomerular epithelial cells
23. Experimental glomerulonephritis
24. Antiglomerular basement membrane nephritis in the mouse
25. Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b
26. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis
27. Mouse decay-accelerating factor: Selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form
28. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes: Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms
29. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting
30. CD59 protects rat kidney from complement mediated injury in collaboration with Crry
31. A critical role for murine complement regulator Crry in fetomaternal tolerance